Literature DB >> 8032586

Induction of kinin B1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery.

D Pruneau1, J M Luccarini, C Robert, P Bélichard.   

Abstract

1. Balloon catheter injury to the rabbit carotid artery damaged the endothelium and induced neointima formation over 7 days. The area of intima, expressed as a percentage of the media, was 16.2 +/- 4.2% and 8.2 +/- 0.1% in balloon catheter-injured and sham-operated arteries. 2. Seven days after arterial injury, carotid arteries were isolated and set up as ring preparations in organ baths for isometric tension measurements. Balloon catheter-injured arteries first contracted with noradrenaline (0.01-0.1 microM), contracted further in a concentration-dependent manner to bradykinin (BK; pD2, 5.98 +/- 0.22; Emax, 41.3 +/- 5.2% of KCl) and to des-Arg9-BK (pD2, 7.12 +/- 0.36; Emax, 46.0 +/- 9.9% of KCl). In contrast, vessel segments with endothelium either intact or acutely removed were unresponsive to both BK receptor agonists. 3. The concentration-contraction curves for BK and for des-Arg9-BK were shifted to the right by the B1 receptor antagonist, [Leu8]des-Arg9-BK (3 microM), but not by the selective B2 receptor antagonist, Hoe 140 (1 microM). 4. Thus, BK and its metabolite, des-Arg9-BK act as vasoconstrictor agents following balloon catheter injury. These effects appear to be mediated by activation of B1 receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032586      PMCID: PMC1910121          DOI: 10.1111/j.1476-5381.1994.tb14847.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Methodological approaches for the study of the aortic endothelium of the rat.

Authors:  M Gabaldón
Journal:  Atherosclerosis       Date:  1987-05       Impact factor: 5.162

2.  The ability of des-Arg9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubation.

Authors:  D Deblois; F Marceau
Journal:  Eur J Pharmacol       Date:  1987-10-06       Impact factor: 4.432

Review 3.  Pharmacology of kinins: their relevance to tissue injury and inflammation.

Authors:  F Marceau; A Lussier; D Regoli; J P Giroud
Journal:  Gen Pharmacol       Date:  1983

4.  Induction of bradykinin B1 receptor-mediated relaxation in the isolated rabbit carotid artery.

Authors:  D Pruneau; P Bélichard
Journal:  Eur J Pharmacol       Date:  1993-08-03       Impact factor: 4.432

Review 5.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

6.  Angiotensin converting enzyme inhibitors and expression of des-Arg9-BK (kinin B1) receptors in vivo.

Authors:  I A Nwator; E T Whalley
Journal:  Eur J Pharmacol       Date:  1989-01-24       Impact factor: 4.432

7.  Activation of protein formation and cell division by bradykinin and des-Arg9-bradykinin.

Authors:  R H Goldstein; M Wall
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

8.  Hypotensive effect of bradykinin in normotensives and patients with renovascular hypertension.

Authors:  G Bönner; U Schunk
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

Review 9.  Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.

Authors:  M W Liu; G S Roubin; S B King
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

10.  Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis is increased by expression of a mutant ras oncogene.

Authors:  R A Roberts; W J Gullick
Journal:  J Cell Sci       Date:  1989-11       Impact factor: 5.285

View more
  9 in total

1.  Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats.

Authors:  P Belichard; J M Luccarini; E Defrêne; P Faye; R M Franck; H Duclos; J L Paquet; D Pruneau
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  Endothelial kinin B(1)-receptors are induced by myocardial ischaemia-reperfusion in the rabbit.

Authors:  C Mazenot; L Loufrani; D Henrion; C Ribuot; W Muller-Esterl; D Godin-Ribuot
Journal:  J Physiol       Date:  2001-01-01       Impact factor: 5.182

3.  Improved endothelial dysfunction by Cynanchum wilfordii in apolipoprotein E(-/-) mice fed a high fat/cholesterol diet.

Authors:  Deok Ho Choi; Yun Jung Lee; Hyun Cheol Oh; Ying Lan Cui; Jin Sook Kim; Dae Gill Kang; Ho Sub Lee
Journal:  J Med Food       Date:  2011-11-14       Impact factor: 2.786

4.  The role of inflammation and COX-derived prostanoids in the effects of bradykinin on isolated rat aorta and urinary bladder.

Authors:  Kevser Erol; Basar Sirmagul; Fatma Sultan Kilic; Semra Yigitaslan; Ali Evrim Dogan
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

5.  Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery.

Authors:  G R Drummond; T M Cocks
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  Regulation of kinin-induced contraction and DNA synthesis by inflammatory cytokines in the smooth muscle of the rabbit aorta.

Authors:  L Levesque; J F Larrivée; D R Bachvarov; F Rioux; G Drapeau; F Marceau
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

7.  The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.

Authors:  S Meini; A Lecci; C A Maggi
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

8.  Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.

Authors:  P Bélichard; B Loillier; J L Paquet; J M Luccarini; D Pruneau
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

9.  Participation of kinins in the captopril-induced inhibition of intimal hyperplasia caused by interruption of carotid blood flow in the mouse.

Authors:  C Emanueli; M Bonaria Salis; C Figueroa; J Chao; L Chao; L Gaspa; M C Capogrossi; P Madeddu
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.